Is TEM a good stock to buy? We came across a bullish thesis on Tempus AI, Inc. on Joe Gannon’s Substack by Gannon Capital. In ...

The blended fair value estimate for Tempus AI has been adjusted slightly, moving from US$72.73 to US$72.40 as part of the ...

Tempus AI (TEM) stock gains after being named to TIME's influential health companies list, with Q1 earnings expected May 5 ...

TEM and ILMN battle in precision oncology, but stronger stock gains, valuation and earnings outlook position ILMN as the more compelling pick now.

Multiple class action cases have been filed against Tempus AI alleging that, during its acquisition of Ambry Genetics, the company improperly collected and disclosed genetic information without ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that the company will host an Investor Day on Friday, May 29, 2026. The ...

Tempus AI Inc. (NASDAQ:TEM) is one of the best up and coming stocks with highest upside potential. On April 23, Tempus AI and ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company advancing precision medicine through the practical application of artificial intelligence, today announced it has been named to TIME's 10 Most ...

Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...

Shares of Tempus AI rose after the medical technology company said it was expanding the commercial availability of whole-genome sequencing assay technology to detect and analyze cancer cells in ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Predicta Biosciences, a precision oncology company ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it will report financial results for the first quarter ended March 31, ...